S(N)1-type alkylating agents that produce cytotoxic O(6)-methyl-G (O(6)-meG) DNA adducts induce cell cycle arrest and apoptosis in a manner requiring the DNA mismatch repair (MMR) proteins MutSalpha and MutLalpha. Here, we show that checkpoint signaling in response to DNA methylation occurs during S phase and requires DNA replication that gives rise to O(6)-meG/T mispairs. DNA binding studies reveal that MutSalpha specifically recognizes O(6)-meG/T mispairs, but not O(6)-meG/C. In an in vitro assay, ATR-ATRIP, but not RPA, is preferentially recruited to O(6)-meG/T mismatches in a MutSalpha- and MutLalpha-dependent manner. Furthermore, ATR kinase is activated to phosphorylate Chk1 in the presence of O(6)-meG/T mispairs and MMR proteins. These results suggest that MMR proteins can act as direct sensors of methylation damage and help recruit ATR-ATRIP to sites of cytotoxic O(6)-meG adducts to initiate ATR checkpoint signaling.
ATR kinase activation mediated by MutSalpha and MutLalpha in response to cytotoxic O6-methylguanine adducts. Publishing Authors By Initials
ATR kinase activation mediated by MutSalpha and MutLalpha in response to cytotoxic O6-methylguanine adducts. Journal Published:
PUBLICATION TYPE: Research Support, N.I.H., Intr
Journal: Molecular cell
VOLUME: 22
Page Numbers: 501-10
Journal Abbreviation: Mol. Cell
ISSN: 1097-2765
DAY: 19
MONTH: May
YEAR: 2006
ATR kinase activation mediated by MutSalpha and MutLalpha in response to cytotoxic O6-methylguanine adducts. Information
Number of References:
LANGUAGE: eng
NlmUniqueID: 9802571
ATR kinase activation mediated by MutSalpha and MutLalpha in response to cytotoxic O6-methylguanine adducts. Keywords Mesh Terms:
KEYWORDS: Signal Transduction
MESH TERMS: metabolism
Chemical & Substance for Abstract: ATR kinase activation mediated by MutSalpha and MutLalpha in response to cytotoxic O6-methylguanine adducts. Information
Substance Name: MutS DNA Mismatch-Binding Protein
Registry Number: EC 3.6.1.3
Grant and Affiliation Information for ATR kinase activation mediated by MutSalpha and MutLalpha in response to cytotoxic O6-methylguanine adducts.
AFFILIATION: Genetics and Biochemistry Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.
Country: United States
AGENCY:
GRANT:
ACRONYM:
MEDLINETA: Mol Cell
REFSOURCE:
DATABASENAME:
ACCESSION NUMBER:
Number Hits: 0
ATR kinase activation mediated by MutSalpha and MutLalpha in response to cytotoxic O6-methylguanine adducts Related Publications